Celgene Corp (NASDAQ:CELG)

108.79
Delayed Data
As of Aug 26
 +0.88 / +0.82%
Today’s Change
93.05
Today|||52-Week Range
128.39
-9.16%
Year-to-Date
Jim Cramer's 'Mad Money' Recap: Markets Make This Economy, Not the Fed
Aug 25 / TheStreet.com - Paid Partner Content
Stocks Struggle for Direction as Jackson Hole Conference Looms
Aug 22 / TheStreet.com - Paid Partner Content
Dear Pfizer, Stop Overpaying for Acquisitions!
Aug 24 / MotleyFool.com - Paid Partner Content
Biotechs Rally on Pfizer/Medivation Deal
Aug 22 / TheStreet.com - Paid Partner Content
Remember the Dow's 1,000 point plunge?
Aug 24 / CNNMoney.com
Pfizer nears $14bn takeover of Medivation
Aug 21 / FT.com - Paid Partner Content
Medivation Scores Premium in Sale to Pfizer
Aug 22 / TheStreet.com - Paid Partner Content
3 Top Stocks You Can Buy on Sale
Aug 21 / MotleyFool.com - Paid Partner Content
ETFs in Focus on Pfizer's Medivation Acquisition
Aug 22 / Zacks.com - Paid Partner Content
3 Reasons Medivation Is the Juiciest Target in Biotech
Aug 21 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close107.91
Today’s open107.93
Day’s range107.50 - 110.13
Volume4,728,358
Average volume (3 months)4,396,952
Market cap$83.6B
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-18.83%
Earnings growth (this year)+22.42%
Earnings growth (next 5 years)+20.49%
Revenue growth (last year)+16.47%
P/E ratio45.7
Price/Sales11.10
Price/Book14.34

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.18-0.54%
LLYEli Lilly and Co+0.23+0.29%
NVONovo Nordisk+0.04+0.09%
AGNAllergan+1.62+0.69%
Data as of 4:02pm ET, 08/26/2016

Financials

Next reporting dateOctober 20, 2016
EPS forecast (this quarter)$1.48
Annual revenue (last year)$8.9B
Annual profit (last year)$1.6B
Net profit margin18.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President, Chief Operating Officer &
Director
Jacqualyn A. Fouse
Corporate headquarters
Summit, New Jersey

Forecasts

Partner Offers

NextAdvisor